Linhong He

# 22 Shuangyong Road
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Induction and Propagation of Ferroptosis Evasion by FTH1P7 Drives Sorafenib Resistance in Hepatocellular Carcinoma.

Induction and Propagation of Ferroptosis Evasion by FTH1P7 Drives Sorafenib Resistance in Hepatocellular Carcinoma.

Journal: European journal of pharmacology
Published: May 05, 2026

Design, Synthesis, and Mechanism Study of Novel BMX Inhibitors Based on the Core of 1,3,5-Triazin-2-Amine for the Treatment of Gastric Carcinoma.

Design, Synthesis, and Mechanism Study of Novel BMX Inhibitors Based on the Core of 1,3,5-Triazin-2-Amine for the Treatment of Gastric Carcinoma.

Journal: Journal of medicinal chemistry
Published: February 15, 2025

Structural Optimizations on the Scaffold of 7H-Pyrrolo[2,3-d]Pyrimidine to Develop Potent iNOS Inhibitors With Improved Antiarthritis Activity In Vivo.

Structural Optimizations on the Scaffold of 7H-Pyrrolo[2,3-d]Pyrimidine to Develop Potent iNOS Inhibitors With Improved Antiarthritis Activity In Vivo.

Journal: Archiv der Pharmazie
Published: January 21, 2025

FTH1P8 induces and transmits docetaxel resistance by inhibiting ferroptosis in prostate cancer.

FTH1P8 induces and transmits docetaxel resistance by inhibiting ferroptosis in prostate cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 17, 2024

Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold.

Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold.

Journal: Molecular diversity
Published: January 09, 2024

Structural optimizations on the 7H-pyrrolo[2,3-d]pyrimidine scaffold to develop highly selective, safe and potent JAK3 inhibitors for the treatment of Rheumatoid arthritis.

Structural optimizations on the 7H-pyrrolo[2,3-d]pyrimidine scaffold to develop highly selective, safe and potent JAK3 inhibitors for the treatment of Rheumatoid arthritis.

Journal: Bioorganic chemistry
Published: January 01, 2024

Design and synthesis of highly selective Janus kinase 3 covalent inhibitors for the treatment of rheumatoid arthritis.

Design and synthesis of highly selective Janus kinase 3 covalent inhibitors for the treatment of rheumatoid arthritis.

Journal: Archiv der Pharmazie
Published: December 21, 2023

Detection of the freshness of rice by chemiluminescence.

Detection of the freshness of rice by chemiluminescence.

Journal: Luminescence : the journal of biological and chemical luminescence
Published: October 10, 2022

Corrigendum to "Optimization of the benzamide fragment targeting the S2' site leads to potent dipeptidyl Peptidase-IV inhibitors" [Bioorg. Chem. 94 (2020) 103366].

Corrigendum to "Optimization of the benzamide fragment targeting the S2' site leads to potent dipeptidyl Peptidase-IV inhibitors" [Bioorg. Chem. 94 (2020) 103366].

Journal: Bioorganic chemistry
Published: May 17, 2020

Optimization of the benzamide fragment targeting the S2' site leads to potent dipeptidyl peptidase-IV inhibitors.

Optimization of the benzamide fragment targeting the S2' site leads to potent dipeptidyl peptidase-IV inhibitors.

Journal: Bioorganic chemistry
Published: July 11, 2019

Design, synthesis, and biological evaluation of quinazoline derivatives as dual HDAC1 and HDAC6 inhibitors for the treatment of cancer.

Design, synthesis, and biological evaluation of quinazoline derivatives as dual HDAC1 and HDAC6 inhibitors for the treatment of cancer.

Journal: Chemical biology & drug design
Published: January 29, 2018

Design, synthesis, and SAR study of highly potent, selective, irreversible covalent JAK3 inhibitors.

Design, synthesis, and SAR study of highly potent, selective, irreversible covalent JAK3 inhibitors.

Journal: Molecular diversity
Published: April 29, 2017
Showing 1-12 of 12

Last Updated: 09/26/2026